Preclinical efficacy profiles of the sigma‐1 modulator E1R and of fenfluramine in two chronic mouse epilepsy models

Ähnliche Einträge

• Drug discovery and preclinical testing of drug candidates for developmental and epileptic encephalopathies
  von: Heidrun Potschka, et al.
  Veröffentlicht: (2025)
• Comprehensive scoping review of fenfluramine's role in managing generalized tonic–clonic seizures in developmental and epileptic encephalopathies
  von: Antonio Gil‐Nagel, et al.
  Veröffentlicht: (2024)
• Enantioselective comparative analysis of the anticonvulsant potency of fenfluramine and norfenfluramine in mice
  von: Yara Sheeni, et al.
  Veröffentlicht: (2025)
• Chemogenetic astrocyte modulation reduces spontaneous hippocampal discharges and metabolite changes in an epilepsy mouse model
  von: Liam Nestor, et al.
  Veröffentlicht: (2025)
• Comparative efficacy and safety of stiripentol, cannabidiol and fenfluramine as first‐line add‐on therapies for seizures in Dravet syndrome: A network meta‐analysis
  von: Renzo Guerrini, et al.
  Veröffentlicht: (2024)